top of page

Some questions from our customers…

“I seem to waste a lot of comparator
drugs throughout my studies…?”

“My current CRO does not seem to understand the complexities of
starting a psychedelic based study…”

“I realise that my bill of materials
contains some single source materials…can you help me sort
that out…”

“Where can I find an ERP solution provider for a platform I am currently working on involving a large number of suppliers and hospitals?”

“What kind of supply chain solutions are in development or available to support my hospital based cell therapy manufacturing process?”

“I want to expand in Europe, can you help me find some potential target companies…”

“I need to focus on another priority,
can you help manage this project for
me for a few months...”

“I need to review the contracts in place with my top 15 vendors…”

“I need a new alternative supplier to manage my clinical supplies…”

“My supplier is really not performing and I cannot see how to turn this around…”

...What is your's ?

Case studies

Case Study 1:
Build trust to help innovation
Acting as trusted intermediary between sponsor & supplier

• Situation – Sponsor unhappy with supplier performance.  Emotions clouding discussions.

• Solution – An impartial, root cause analysis identified that both parties were partially to blame on performance issues --  implementation of improve supplier governance, with clearer responsibilities and simplified communication channels

Key Consideration: ensure you keep a win-win environment ,  give a long term perspective to your relationship to vendors
Consultation d'affaires
Case Study 2:
Clinical supplies category refresh
Changing the relationship using a procurement process driven category update

• Situation – Sponsor unhappy with supplier performance and single source situation driving lack of motivation on supplier side

• Solution – Market research, identification of 5 options, data driven assessment and implementation of a second clinical supply and distribution outsourced solution, including LN2 warehousing capabilities globally

Key Consideration: avoid single source, give a long term perspective to your relationship to vendors
Case Study 3:
Comparator usage optimisation
Reducing overall study budget

• Situation – comparators/reference drug overage and wastage worth over 1M$+/year

• Solution – sale of unused product and implementation of an usage optimization solution (USA), identification of several options, data driven assessment and implementation of a second comparators and ancillaries sourcing solution

Key Consideration: think beyond product purchase cost and look at optimizing the overall product usage and wastage
Pilules quotidiennes
Case Study 4:
Compliance support
Ensuring regulatory requirements

• Situation -  Health Authority GCP inspection for a study

• Solution -  Presentation of supplier selection and management processes to authorities , detailing due diligence and risk assessment of suppliers involved – no non-compliance identified

Key Consideration: you have to explain and demonstrate your vendor selection process to the competent authorities 
In a Meeting
Case Study 5:
Supply chain services for decentralized cell therapies 
Helping develop a concept by finding suitable partners to develop a new set of services to serve hospital based cell therapy manufacturing 

• Situation - next generation cell therapy start up looking for partners to manage their supply chain including new set of services not yet available


• Solution – Identification of actors in the field and engagement, including via a consortium approach (one can not do all),  to co-develop new solutions under the supervision of the client

Key Consideration: build a vision to bring your partners to invest time and expertise in your concept
Case Study 6:
Cell therapy Tracking System and beyond
Identifying the IT solution to build a customized solution 

• Situation - next generation cell therapy startup looking for a IT platform to build their new approach to cell therapies


• Solution – Identification of key current and upcoming actors in the cell therapy field (CoC and CoI) field and engagement to co-develop a new solution starting with a strong recognized basis.

Key Consideration: data integration and technical expertise are key, common goals and aligned company cultures are essential.
Processeur informatique
bottom of page